FDA Drug Application (019583) for RELAFEN by SMITHKLINE BEECHAM

Back to FDA Applications sponsored by SMITHKLINE BEECHAM

Application Number019583
Product Number001
FormTABLET;ORAL
Dosage500MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRELAFEN
Active IngredientNABUMETONE

Active IngredientCount
List of drugs with Active Ingredient NABUMETONE2


Back to FDA Applications sponsored by SMITHKLINE BEECHAM